Powered by
Vanc Pharmaceuticals down 8.9% in 2 days March 01, 2017 17:00 EST
Mar 1, 2017 - News Bites Canadian Markets


Vanc Pharmaceuticals Inc. (TSXV:VANC), Canada's 10th largest Drug manufacturers company by market cap, extended its slide on Wednesday, shedding an additional 1.50c (5.6%) to close at 25.50c. The shares have tumbled 2.50c (8.9%) over the past two trading days, compared with the S&P/TSX 60 Index which rose 6.3 points (0.7%) in the two days for a relative price change of -9.6%. Volume in the 2 days was 0.4 times the average daily volume of 46,041 shares.


Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox